Toxoplasmosis injection boost

Use of an intravitreal injection of steroid and antibiotic is more effective than the traditional systemic route in treating toxoplasmosis.

A study from Iran, published in this month's Ophthalmology, has shown that the intravitreal treatment was both more convenient and had much less risk of side effects than systemic drug use.

Toxoplasmosis is the most significant cause of chorioretinitis (posterior uveitis) and can cause significant vision loss.